These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19222623)

  • 1. The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas.
    Pertel PE; Eisenstein BI; Link AS; Donfrid B; Biermann EJ; Bernardo P; Martone WJ
    Int J Clin Pract; 2009 Mar; 63(3):368-75. PubMed ID: 19222623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
    Davis SL; McKinnon PS; Hall LM; Delgado G; Rose W; Wilson RF; Rybak MJ
    Pharmacotherapy; 2007 Dec; 27(12):1611-8. PubMed ID: 18041881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Controlled Noninferiority Trial Comparing Daptomycin to Vancomycin for the Treatment of Complicated Skin and Skin Structure Infections in an Observation Unit.
    Shaw GJ; Meunier JM; Korfhagen J; Wayne B; Hart K; Lindsell CJ; Fermann G
    J Emerg Med; 2015 Dec; 49(6):928-36. PubMed ID: 26433431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
    Arbeit RD; Maki D; Tally FP; Campanaro E; Eisenstein BI;
    Clin Infect Dis; 2004 Jun; 38(12):1673-81. PubMed ID: 15227611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
    Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ
    Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections.
    Knapp AG; Kamepalli RK; Martone WJ; Yankelev S
    Surg Infect (Larchmt); 2011 Apr; 12(2):113-8. PubMed ID: 21348765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More Frequent Premature Antibiotic Discontinuations and Acute Kidney Injury in the Outpatient Setting With Vancomycin Compared to Daptomycin.
    Tuerff D; Nunez M
    J Clin Pharmacol; 2020 Mar; 60(3):384-390. PubMed ID: 31630403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
    Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
    Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
    Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.
    Ferreira A; Bolland MJ; Thomas MG
    Infection; 2016 Oct; 44(5):607-15. PubMed ID: 27085865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome.
    Klotz C; Courjon J; Michelangeli C; Demonchy E; Ruimy R; Roger PM
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):703-709. PubMed ID: 30685804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellulitis and erysipelas.
    Morris A
    Clin Evid; 2002 Jun; (7):1483-7. PubMed ID: 12230764
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin experience in critical care patients: results from a registry.
    Brown JE; Fominaya C; Christensen KJ; McConnell SA; Lamp KC
    Ann Pharmacother; 2012 Apr; 46(4):495-502. PubMed ID: 22454446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
    Schrank GM; Wright SB; Branch-Elliman W; LaSalvia MT
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):947-954. PubMed ID: 29893658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
    Jobson S; Moise PA; Eskandarian R
    Clin Ther; 2011 Oct; 33(10):1391-9. PubMed ID: 22015328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.